Abstract

Abstract: Randomized controlled trials (RCTs) are the gold standard method for developing evidence-based medicine ininflammatory bowel disease (IBD).Methodological problems in RCTs in IBD concern different aspects such as the definition of the study population due tothe extreme variability of patients with IBD, the indices of disease activity, a clearly defined outcome, the environmentalrisk factors (i.e smoking behaviour) that may influence the randomization, the heterogeneous placebo rate of remissionand the different statistical methods used to analyze the results.It is important that trials are designed efficiently, done well and complement clinical practice with a careful subject selection,standardization of disease activity indices, and precise outcome measurement in order to continue the improvementof the IBD research process.
Lingua originaleEnglish
pagine (da-a)284-289
Numero di pagine6
RivistaReviews on Recent Clinical Trials
Volume7
Stato di pubblicazionePublished - 2012

Fingerprint

Randomized Controlled Trials
Evidence-Based Medicine
Random Allocation
Patient Selection
Smoking
Placebos
Research
Population

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cita questo

Methodological problems in RCTson IBD. / Cottone, Mario.

In: Reviews on Recent Clinical Trials, Vol. 7, 2012, pag. 284-289.

Risultato della ricerca: Article

@article{0077c61439ee473aab6fad729c793256,
title = "Methodological problems in RCTson IBD",
abstract = "Abstract: Randomized controlled trials (RCTs) are the gold standard method for developing evidence-based medicine ininflammatory bowel disease (IBD).Methodological problems in RCTs in IBD concern different aspects such as the definition of the study population due tothe extreme variability of patients with IBD, the indices of disease activity, a clearly defined outcome, the environmentalrisk factors (i.e smoking behaviour) that may influence the randomization, the heterogeneous placebo rate of remissionand the different statistical methods used to analyze the results.It is important that trials are designed efficiently, done well and complement clinical practice with a careful subject selection,standardization of disease activity indices, and precise outcome measurement in order to continue the improvementof the IBD research process.",
author = "Mario Cottone",
year = "2012",
language = "English",
volume = "7",
pages = "284--289",
journal = "Reviews on Recent Clinical Trials",
issn = "1574-8871",
publisher = "Bentham Science Publishers B.V.",

}

TY - JOUR

T1 - Methodological problems in RCTson IBD

AU - Cottone, Mario

PY - 2012

Y1 - 2012

N2 - Abstract: Randomized controlled trials (RCTs) are the gold standard method for developing evidence-based medicine ininflammatory bowel disease (IBD).Methodological problems in RCTs in IBD concern different aspects such as the definition of the study population due tothe extreme variability of patients with IBD, the indices of disease activity, a clearly defined outcome, the environmentalrisk factors (i.e smoking behaviour) that may influence the randomization, the heterogeneous placebo rate of remissionand the different statistical methods used to analyze the results.It is important that trials are designed efficiently, done well and complement clinical practice with a careful subject selection,standardization of disease activity indices, and precise outcome measurement in order to continue the improvementof the IBD research process.

AB - Abstract: Randomized controlled trials (RCTs) are the gold standard method for developing evidence-based medicine ininflammatory bowel disease (IBD).Methodological problems in RCTs in IBD concern different aspects such as the definition of the study population due tothe extreme variability of patients with IBD, the indices of disease activity, a clearly defined outcome, the environmentalrisk factors (i.e smoking behaviour) that may influence the randomization, the heterogeneous placebo rate of remissionand the different statistical methods used to analyze the results.It is important that trials are designed efficiently, done well and complement clinical practice with a careful subject selection,standardization of disease activity indices, and precise outcome measurement in order to continue the improvementof the IBD research process.

UR - http://hdl.handle.net/10447/73836

M3 - Article

VL - 7

SP - 284

EP - 289

JO - Reviews on Recent Clinical Trials

JF - Reviews on Recent Clinical Trials

SN - 1574-8871

ER -